Geode Capital Management’s Serina Therapeutics SER Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $178K | Sell |
28,884
-322
| -1% | -$1.98K | ﹤0.01% | 3911 |
|
|
2025
Q1 | $166K | Buy |
29,206
+3,010
| +11% | +$17.1K | ﹤0.01% | 3899 |
|
|
2024
Q4 | $131K | Buy |
26,196
+2,170
| +9% | +$10.9K | ﹤0.01% | 4025 |
|
|
2024
Q3 | $161K | Buy |
24,026
+1,279
| +6% | +$8.56K | ﹤0.01% | 3979 |
|
|
2024
Q2 | $218K | Buy |
+22,747
| New | +$218K | ﹤0.01% | 3876 |
|
|
2024
Q1 | – | Sell |
-140,994
| Closed | -$54.3K | – | 4642 |
|
|
2023
Q4 | $54.3K | Hold |
140,994
| – | – | ﹤0.01% | 4327 |
|
|
2023
Q3 | $95.9K | Buy |
140,994
+43,230
| +44% | +$29.4K | ﹤0.01% | 4266 |
|
|
2023
Q2 | $87.3K | Hold |
97,764
| – | – | ﹤0.01% | 4377 |
|
|
2023
Q1 | $64.8K | Sell |
97,764
-1,847
| -2% | -$1.23K | ﹤0.01% | 4459 |
|
|
2022
Q4 | $54K | Sell |
99,611
-252
| -0.3% | -$137 | ﹤0.01% | 4575 |
|
|
2022
Q3 | $56K | Hold |
99,863
| – | – | ﹤0.01% | 4741 |
|
|
2022
Q2 | $57K | Buy |
99,863
+1,465
| +1% | +$836 | ﹤0.01% | 4749 |
|
|
2022
Q1 | $84K | Hold |
98,398
| – | – | ﹤0.01% | 4707 |
|
|
2021
Q4 | $107K | Hold |
98,398
| – | – | ﹤0.01% | 4710 |
|
|
2021
Q3 | $92K | Hold |
98,398
| – | – | ﹤0.01% | 4698 |
|
|
2021
Q2 | $152K | Hold |
98,398
| – | – | ﹤0.01% | 4441 |
|
|
2021
Q1 | $159K | Hold |
98,398
| – | – | ﹤0.01% | 4187 |
|
|
2020
Q4 | $149K | Hold |
98,398
| – | – | ﹤0.01% | 3969 |
|
|
2020
Q3 | $79K | Hold |
98,398
| – | – | ﹤0.01% | 3950 |
|
|
2020
Q2 | $93K | Sell |
98,398
-106,505
| -52% | -$101K | ﹤0.01% | 3871 |
|
|
2020
Q1 | $190K | Buy |
204,903
+5,452
| +3% | +$5.06K | ﹤0.01% | 3566 |
|
|
2019
Q4 | $363K | Buy |
199,451
+153
| +0.1% | +$278 | ﹤0.01% | 3608 |
|
|
2019
Q3 | $390K | Buy |
199,298
+5,754
| +3% | +$11.3K | ﹤0.01% | 3556 |
|
|
2019
Q2 | $710K | Buy |
193,544
+65,857
| +52% | +$242K | ﹤0.01% | 3336 |
|
|
2019
Q1 | $517K | Buy |
127,687
+5,170
| +4% | +$20.9K | ﹤0.01% | 3430 |
|
|
2018
Q4 | $366K | Buy |
+122,517
| New | +$366K | ﹤0.01% | 3479 |
|